Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2021 Jan 6;22(1):9. doi: 10.1186/s13063-020-04964-1.
Trials. 2021.
PMID: 33407777
Free PMC article.